ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0911

Activating B Cells Facilitates the Discovery of Latent Disease-associated Variants

David Murphy, Yao Fu, Jennifer Kelly, Richard Pelikan, Graham Wiley and Patrick Gaffney, Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, B-Lymphocyte, Genome Wide Association Studies, genomics, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Although millions of disease-associated variants have been discovered using GWAS, most of these occur in non-coding regions and their mechanistic link to disease is unclear. Further, separating causal from neutral variants within haplotypes remains challenging. Analyses of expression quantitative trait loci (eQTLs) in healthy tissues only explain some GWAS hits due to the different mechanisms driving variant discovery in these two approaches. Quantitative trait loci associated with epigenomic phenotypes such as chromatin accessibility (caQTL) and histone modifications (hQTL) may reveal genetically mediated regulatory mechanisms not detected by traditional eQTL analysis. Moreover, latent disease-specific mechanisms encoded in the epigenome may be elicited by stimulating healthy tissues.

Methods: We gathered expression data using RNA-seq, epigenomic data using ATAC-seq and CUTNRUN (for H3K27-acetylation and CTCF-binding), from B cells in 81 genotyped, healthy individuals from both a resting and immune-stimulated condition. Stimulation consisted of a 48-hour treatment with BCR crosslinking, CD40 co-stimulation and TLR7 agonist.

Results: We identified strong effects of stimulation across these “omic” layers, including thousands of differentially expressed genes and tens of thousands of differentially activated epigenomic modifications triggered by stimulation. Pairing this omics data with polymorphism data from our sample, we identified over 400,000 candidate QTLs, with over 1/3 of these exclusive to the stimulated state. We used the DegCre method to connect differentially expressed genes (DEG) with candidate regulatory elements (CRE) from our epigenomic data. In the context of our stimulation approach, DegCre identifies DEG-CRE associations based on the strength of coordinated changes across omic layers induced by stimulation. Using this approach, we identified over 24,000 significant associations between DEGs and CREs, with many genes apparently regulated by multiple CREs. Among omic layers, differential chromatin accessibility induced by stimulation had the most numerous associations with DEGs, with 20,018 distinct regions, followed by 3,276 regions of differential H3K27 acetylation and 858 regions of differential CTCF binding. The spatial distribution of CREs from each omic layer was mostly non-overlapping. We then examined 8,595 Systemic Lupus Erythematosus (SLE) GWAS variants and found that 1,670 of these matched QTLs that we identified in our data, with 201 matching QTLs exclusively identified in the stimulated B cell state. An additional 536 SLE-associated variants, that did not match any of our QTLs, resided within CREs that we identified with DegCre, supporting the idea that non-coding GWAS variants that do not manifest as QTLs may still be functionally annotated to better identify candidate regulatory elements for experimental validation.

Conclusion: Collectively, our results demonstrate the utility of a multi-omic, stimulation-augmented approach for annotating non-coding GWAS variants and identifying regulatory epigenomic modifications.


Disclosures: D. Murphy: None; Y. Fu: None; J. Kelly: None; R. Pelikan: None; G. Wiley: None; P. Gaffney: None.

To cite this abstract in AMA style:

Murphy D, Fu Y, Kelly J, Pelikan R, Wiley G, Gaffney P. Activating B Cells Facilitates the Discovery of Latent Disease-associated Variants [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/activating-b-cells-facilitates-the-discovery-of-latent-disease-associated-variants/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activating-b-cells-facilitates-the-discovery-of-latent-disease-associated-variants/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology